Pulmonary Diseases

Advertisement

cGxPJobs Banner

Savara Highlights Molgramostim Phase 3 Data at ERS 2026

YARDLEY, Pa., August 24, 2026 Savara Inc. will present new and previously reported Phase 3 IMPALA-2 clinical trial data...

By cGxPwire Editor
August 26, 2026

Read More

Advertisement

cGxPJobs

Directory